• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Inflammation a target for dry eye

Article

Despite recent advances in understanding of dry eye disease, diagnosis of this common disorder still depends on a multipronged evaluation combination findings from patient history and clinical examination.

Key Points

Philadelphia-Despite recent advances in understanding of dry eye disease, diagnosis of this common disorder still depends on a multipronged evaluation combining findings from patient history and clinical examination.

"Relieving bothersome symptoms associated with dry eye disease and improving patient quality of life depends on accurate diagnosis and appropriate treatment," said Dr. Rapuano, director of the Cornea Service and co-director of the Refractive Surgery Department, Wills Eye Institute, and professor of ophthalmology, Thomas Jefferson University, Philadelphia. "There is no single test [to diagnose] dry eye, and the focus of the evaluation is to identify signs and symptoms that differentiate dry eye disease from other conditions that can mimic it or co-exist and contribute to the problem.

© 2024 MJH Life Sciences

All rights reserved.